Clinician Name

Dr Phil Choi

Professional qualification

Haematologist

about

Position Consultant Haematologist

Primary Location The Canberra Hospital, Yamba Drive, Garran ACT, Australia

Referral Required Yes

ITP Patients Treated Adult Patients,

Memberships HSANZ Member, THANZ Member,

Career Bio

Haematologist and clinician researcher in immune haematology - ITP, wAIHA, HIT and drug induced thrombocytopenias

Current Placements

Position Clinic or Hospital Name Suburb State Further Information
Haematology Consultant The Canberra Hospital Garran ACT 0251248479
Visiting Medical Officer National Capital Private Hospital Garran ACT 0262226607

published itp research

  • Choi PY, Merriman E, Bennett A, Enjeti AK, Tan CW, Goncalves I, et al. Updated treatment options for immune thrombocytopenia. Internal Medicine Journal. 2023;In press.
  • Choi PY, Merriman E, Bennett A, Enjeti AK, Tan CW, Goncalves I, et al. Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand. Med J Aust. 2022;216(1):43-52.
  • Choi PY, Hsu D, Tran HA, Tan CW, Enjeti A, Chen VMY, et al. Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients. Res Pract Thromb Haemost. 2023;7(1):100009.
  • Kuter DJ, Efraim M, Mayer J, Trněný M, McDonald V, Bird R, et al. Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia. New England Journal of Medicine. 2022;386(15):1421-31.
  • Choi PY, Hsu D, Tran HA, Tan CW, Enjeti A, Chen VMY, et al. Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica. 2022;107(5):1193-6.
  • Aitken L, Patel R, D'Rozario J, Choi P. Alemtuzumab-induced red cell aplasia and other immune cytopenias: not so ‘pure’. Immunotherapy. 2022;14(2):95-9.
  • Chen VM, Curnow JL, Tran HA, Choi PY. Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia. Med J Aust. 2021;215(6):245-9 e1
  • Choi PY, Gordon JE, Harvey M, Chong BH. Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre. Intern Med J. 2012;42(7):841-5.
  • Choi PY, Roncolato F, Badoux X, Ramanathan S, Ho SJ, Chong BH. A novel triple therapy for ITP using high dose dexamethasone, low dose rituximab and cyclosporine (TT4). Blood. 2015;126(4):500-3.
  • Iraqi M, Perdomo J, Yan F, Choi PY, Chong BH. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Haematologica. 2015;100(5):623-32.
Scroll To Top
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.